Report Published: "Oryzon Genomics S.A. - Product Pipeline Analysis, 2013 Update"
Oryzon Genomics (Oryzon) is a biopharmaceutical company. It develops therapies and biological solutions for cancer and neurodegenerative diseases. The company specializes in the field of preventative medicine. It carries out its operations under three business units, namely, Diagnostics, Personalized Medicine and Therapy. The company's diagnostic products in pipeline include GynEC-DX for endometrial cancer; Cxbladder for bladder cancer; and ColoBRAF for colorectal cancer. It produces NCEs and monoclonal antibodies for Neurogeneration and Cancer. The company offers comprehensive range of services including...
View full press release